XML 154 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Income Taxes (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Schedule of Effective Income Tax Rate Reconciliation

For the nine months ended September 30, 2025, the expected tax expense (benefit) based on the U. S. federal statutory rate is reconciled with the actual tax provision (benefit) as follows:

 

   For the Nine Months Ended
September 30,
 
   2025 
Expected tax at statutory rates        
Federal  $34,000    21%
State   (16,000)   (10)%
Permanent Differences   (1,000)   (1)%
Temporary difference for derivative gain   (738,000)   (461)%
Temporary difference for stock compensation   173,000    108%
Other   70,000    44%
Current Year Change in Valuation Allowance          
Federal   990,000    618%
State   (512,000)   (320)%
Income tax expense  $-    0%

For the years ended December 31, 2024, and 2023, the expected tax expense (benefit) based on the U. S. federal statutory rate is reconciled with the actual tax provision (benefit) as follows:

 

   For the Years Ended
December 31,
 
   2024   2023 
Expected tax at statutory rates  $(528,000)   21%  $(3,463,000)   21%
Permanent Differences   (4,000)   0%   7,000    0%
State Income Tax, Net of Federal benefit   1,019,000    (62)%   (418,000)   1%
Other   1,564,000    (41)%   (95,000)   2%
Current Year Change in Valuation Allowance   (2,051,000)   82%   3,969,000    (24)%
Prior Year True-Ups   -    0%   -    0%
Income tax expense  $-    0%  $-    0%
Schedule of Deferred Tax Assets and Liabilities As of September 30, 2025, and December 31, 2024, significant components of the Company’s deferred tax assets are as follows:
   As of 
   September 30,
2025
   December 31,
2024
 
Deferred Tax Assets (Liabilities):        
Accrued payroll  $141,000   $141,000 
ASC842-ROU (Liability)   822,000    822,000 
Loss from derivatives   (203,000)   (869,000)
Stock based compensation   (460,000)   (304,000)
Depreciation   3,000    3,000 
Net operating loss   12,942,000    12,462,000 
Net deferred tax assets (liabilities)   13,245,000    12,255,000 
Valuation allowance   (13,245,000)   (12,255,000)
Net deferred tax assets (liabilities)  $-   $- 
As of December 31, 2024, and 2023, significant components of the Company’s deferred tax assets are as follows:
   As of 
   December 31,
2024
   December 31,
2023
 
Deferred Tax Assets (Liabilities):        
Accrued payroll  $141,000   $141,000 
ASC842-ROU Asset   -    - 
ASC842-ROU (Liability)   822,000    822,000 
Loss from derivatives   (869,000)   (16,000)
Waiver and commitment fee shares   -    - 
Stock based compensation   (304,000)   (171,000)
Depreciation   3,000    3,000 
Net operating loss   12,462,000    13,529,000 
Net deferred tax assets (liabilities)   12,255,000    14,308,000 
Valuation allowance   (12,255,000)   (14,308,000)
Net deferred tax assets (liabilities)  $-   $-